US HB4242 | 2023-2024 | 118th Congress
Status
Spectrum: Slight Partisan Bill (Republican 2-1)
Status: Introduced on June 21 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on June 21 2023 - 25% progression
Action: 2023-06-23 - Referred to the Subcommittee on Health.
Pending: House Subcommittee on Health Committee
Text: Latest bill text (Introduced) [PDF]
Summary
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
Title
To direct the Secretary of Health and Human Services, acting through the Commissioner of Food and Drugs, to issue guidance on considerations for conducting clinical trials for psychedelic assisted therapy.
Sponsors
| Rep. Dan Crenshaw [R-TX] | Rep. Mariannette Miller-Meeks [R-IA] | Rep. Ro Khanna [D-CA] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-06-23 | House | Referred to the Subcommittee on Health. |
| 2023-06-21 | House | Referred to the House Committee on Energy and Commerce. |
| 2023-06-21 | House | Introduced in House |
Subjects
US Congress State Sources
| Type | Source |
|---|---|
| Summary | https://www.congress.gov/bill/118th-congress/house-bill/4242/all-info |
| Text | https://www.congress.gov/118/bills/hr4242/BILLS-118hr4242ih.pdf |
